Brightening the Future of Immunology with New Frontiers in Science

By exploring new frontiers in science and technology, we strive to accelerate innovation of transformational medicines that deliver more years of life and quality of life for patients and families living with immune-mediated conditions.

Our Small Molecule Discovery Programs

We announced a planned separation into two entities: Galapagos, and a newly to be formed company (“SpinCo”).

We are exploring partnering opportunities to advance our potential best-in-class small molecule programs.

This includes the TYK2 inhibitor, GLPG3667, currently in Phase 2 development for systemic lupus erythematosus, dermatomyositis, and other potential autoimmune indications.

Immunology Pipeline

Product candidate
Target
Study
Drug class
Indication
Discovery
IND/CTA Enabling
Phase 1
Phase 2
GLPG3667
TYK2

GALACELAGALARISSO

Small molecule

SLEDM

pBIC candidate
Undisclosed
Small molecule
Inflammatory bowel disease
pBIC assets
Multiple
Small molecule
Inflammation/auto-immune disorders

pBIC: potential Best-In-Class; SLE: Systemic lupus erythematosus; DM: Dermatomyositis

Experienced and purpose-driven

Address significant unmet medicals needs in immunology

With over 20 years of research under our belt, we have built a vast proprietary knowledge of disease biology.

By exploring new frontiers in science and technology, we strive to accelerate innovation of transformational medicines that deliver more years of life and quality of life for patients and families living with immune-mediated conditions.

Pioneering for patients

High unmet need for immune-mediated diseases

4 million people worldwide

affected by immune-mediated diseases1

80 types

of immune-mediated diseases

Immune system

mistakenly attacks healthy cells and tissues

Building our immunology portfolio

Our focus in immunology

Striving to deliver targeted treatments for immune-mediated diseases

All about Galapagos

Our corporate presentation

Everything you need to know about Galapagos in one slide deck.

Disease areas

More about our work in Oncology

We are united around our mission to redefine the future of cancer treatment. Our goal is to help people facing cancer live longer, better lives.

Partnerships

Work with us!

We are adding new capabilities, technologies and product candidates through internal and external innovation. Let’s start #PioneeringForPatients, together!